ReviewInternational journal of molecular sciences2022

The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma.

Davide Busato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.